After $1.50 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth. The shares were sold at an average price of $80.00, for a total transaction of $1,626,640.00. CVS Health's dividend payout ratio (DPR) is now 41.32%. It has underperformed by 41.10% the S&P500.
Endocyte Incorporated (NASDAQ:ECYT) had an increase of 1.78% in short interest. The Nli International Inc holds 50,160 shares with $4.08M value, down from 62,340 last quarter. James Inv Research holds 11,160 shares. Approximately 3.3% of the company's stock are short sold. The SI to Dcp Midstream LP's float is 4.01%.
The stock increased 3.57% or $1.99 during the last trading session, reaching $57.74. About 40,293 shares traded. Union Pacific Corporation (NYSE:UNP) has risen 31.45% since January 26, 2017 and is uptrending. It has underperformed by 23.85% the S&P500.
Investors sentiment increased to 1.17 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. Truepoint Inc. increased its position in CVS Health by 8,578.9% during the third quarter.More news: North Korea calls for reunification as Olympic hockey teams join forces
Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. They expect $1.90 EPS, up 11.11% or $0.19 from last year's $1.71 per share. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $98.44. Intrust Natl Bank Na has invested 0.31% in CVS Health Corporation (NYSE:CVS). Howland Cap Mngmt Limited Liability Corp owns 203,402 shares for 1.37% of their portfolio. Waddell & Reed Fin has 0.21% invested in CVS Health Corporation (NYSE:CVS) for 1.16 million shares.
CVS Health Corporation is maintained at an average outperform rating by 23 stock analysts, and there are at least 3.26% of shares outstanding that are now legally short sold. Denton David M sold 237,078 shares worth $18.88M. Pinnacle Advisory Gp Inc, a Maryland-based fund reported 8,215 shares.
At the session level, shares of CVS Health Corporation (NYSE:CVS) moved 0.2% from the open.
Trust Company Of Toledo Na, which manages about $393.64M US Long portfolio, decreased its stake in T Rowe Price Real Estate Fund (TRREX) by 18,720 shares to 166,902 shares, valued at $4.73M in 2017Q3, according to the filing. Novare Capital Mgmt Limited Liability Company holds 48,401 shares or 0.69% of its portfolio. Mutual Of America Capital Management Lc has 0.16% invested in CVS Health Corporation (NYSE:CVS). Murphy Mngmt holds 0.2% or 17,331 shares.More news: Simone Biles, Aly Raisman And Jordyn Wieber React To Larry Nassar Sentencing
Since August 16, 2017, it had 0 buys, and 7 insider sales for $58.32 million activity.
Since January 1, 0001, it had 0 insider buys, and 12 selling transactions for $3.13 million activity. 90,267 shares valued at $7.19M were sold by Moriarty Thomas M on Monday, September 11. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 26, 2017 and is downtrending. Roberts Jonathan C had sold 85,743 shares worth $7.13 million. Another trade for 2,500 shares valued at $199,050 was sold by SWIFT RICHARD J. (NYSE:T), 10 have Buy rating, 1 Sell and 18 Hold. Therefore 72% are positive.
CVS has been the topic of a number of recent analyst reports. The company presently has a consensus rating of "Buy" and a consensus target price of $87.49. Jefferies Group reduced their price target on shares of CVS Health from $86.00 to $76.00 and set a "hold" rating for the company in a research note on Tuesday, November 7th. The stock has "Equal-Weight" rating by Morgan Stanley on Tuesday, September 6. Shareholders of record on Monday, July 24th were paid a dividend of $0.50 per share. The company was maintained on Monday, May 9 by Citigroup. The stock has "Buy" rating by SunTrust on Wednesday, January 18. The rating was maintained by Deutsche Bank with "Hold" on Wednesday, July 22. The firm earned "Hold" rating on Tuesday, November 7 by Loop Capital. Finally, Oppenheimer reaffirmed a "buy" rating and issued a $95.00 price objective on shares of CVS Health in a research report on Monday, October 9th. (NYSE:HP) earned "Buy" rating by Argus Research on Thursday, September 15. The firm has "Overweight" rating by Barclays Capital given on Thursday, March 10. Cowen & Co maintained CVS Health Corporation (NYSE:CVS) on Tuesday, June 13 with "Buy" rating.
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. Massachusetts Financial Services Company who had been investing in Symantec Corp for a number of months, seems to be bullish on the $16.83B market cap company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. It has a 23.9 P/E ratio. Cohen Klingenstein Ltd Llc stated it has 0.37% in AT&T Inc. The company has market cap of $169.50 million. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trial to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of advanced solid tumors; and EC1169, a tubulysin therapeutic that is in Phase I dose escalation trial to treat advanced metastatic castration-resistant prostate cancer. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. Therefore 26% are positive. At&T Inc now has $228.19B valuation. The company was maintained on Wednesday, April 12 by Wells Fargo. The company was downgraded on Monday, June 5 by Wedbush. As per Friday, October 7, the company rating was upgraded by Piper Jaffray. (NASDAQ:ECYT) on Wednesday, November 4 with "Outperform" rating. RBC Capital Markets maintained the stock with "Outperform" rating in Wednesday, August 5 report.More news: Can a Hurricane Improve Growth Prospects? Puerto Rico Thinks So
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.